Safety and Tolerability of FMT Capsules in Healthy Volunteers

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This is a two-part, randomized, double-blind, placebo-controlled, single center study to investigate the safety and tolerability of XBI-302 administered orally in healthy volunteers. The hypothesis of this study is that XBI-302 is safe and well tolerated with the proposed dosing regimens.
Epistemonikos ID: 48a4ebd838eb08bf20fc0843a7593806efeaa900
First added on: Oct 02, 2023